Recent Progress toward Microfluidic Quality Control Testing of Radiopharmaceuticals
Radiopharmaceuticals labeled with short-lived positron-emitting or gamma-emitting isotopes are injected into patients just prior to performing positron emission tomography (PET) or single photon emission tomography (SPECT) scans, respectively. These imaging modalities are widely used in clinical car...
Main Authors: | Noel S. Ha, Saman Sadeghi, R. Michael van Dam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Micromachines |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-666X/8/11/337 |
Similar Items
-
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
by: Jonatan Dewulf, et al.
Published: (2020-07-01) -
Multimodality Imaging in Tumor Angiogenesis: Present Status and Perspectives
by: Artor Niccoli Asabella, et al.
Published: (2017-08-01) -
Dosimetry Calculations of Radiopharmaceuticals
by: Kelbe Jahnke
Published: (2010-01-01) -
Tumor Hypoxia Imaging Agents in Nuclear Medicine
by: Mahtab Mohammadpour, et al.
Published: (2017-01-01) -
A Bayesian Approach To Positron Emission Tomography
by: Mondal, Partha Pratim
Published: (2011)